DrugPatentWatch Database Preview
Investigational Drug Information for Tosedostat
Email this page to a colleague
What is the development status for investigational drug Tosedostat?
Tosedostat is an investigational drug.
There have been 11 clinical trials for Tosedostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Chroma Therapeutics, CTI BioPharma, and National Cancer Institute (NCI).
There are ninety-six US patents protecting this investigational drug and nine hundred and four international patents.
Summary for Tosedostat
| US Patents | 96 |
| International Patents | 904 |
| US Patent Applications | 201 |
| WIPO Patent Applications | 165 |
| Japanese Patent Applications | 67 |
| Clinical Trial Progress | Phase 2 (2012-05-01) |
| Vendors | 48 |
Recent Clinical Trials for Tosedostat
| Title | Sponsor | Phase |
|---|---|---|
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | Washington University School of Medicine | Phase 1/Phase 2 |
| Study of Clinical Efficacy and Safety of Tosedostat in MDS | CTI BioPharma | Phase 2 |
| Study of Clinical Efficacy and Safety of Tosedostat in MDS | Weill Medical College of Cornell University | Phase 2 |
Clinical Trial Summary for Tosedostat
Top disease conditions for Tosedostat
Top clinical trial sponsors for Tosedostat
US Patents for Tosedostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tosedostat | ⤷ Try it Free | Pyrrolidinone derivatives as MetAP-2 inhibitors | Merck Patent GmbH (Darmstadt, DE) | ⤷ Try it Free |
| Tosedostat | ⤷ Try it Free | Heteroaryl compounds as IRAK inhibitors and uses thereof | Merck Patent GmbH (Darmstadt, DE) | ⤷ Try it Free |
| Tosedostat | ⤷ Try it Free | Heteroaryl compounds as BTK inhibitors and uses thereof | Merck Patent GmbH (Darmstadt, DE) | ⤷ Try it Free |
| Tosedostat | ⤷ Try it Free | Heteroaryl compounds as IRAK inhibitors and uses thereof | Merck Patent GmbH (Darmstadt, DE) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tosedostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tosedostat | Argentina | AR101414 | 2034-08-04 | ⤷ Try it Free |
| Tosedostat | Australia | AU2015299431 | 2034-08-04 | ⤷ Try it Free |
| Tosedostat | Brazil | BR112017000730 | 2034-08-04 | ⤷ Try it Free |
| Tosedostat | Canada | CA2957154 | 2034-08-04 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
